speb/financial-data huggingface dataset:
Financial ratios for HIMX — quarterly report dated 2025-09-30
Total revenue: 6538443.86080105
Gross profit: 1973046.6185160866
Operating income: -20288.903479973735
Net income: 44287.59028233749
Capital expenditures: 207386.73670387393
Operating cash flow: 219862.11424819435
Depreciation & amortization: 177051.87130663166
Net tangible assets: 27790282.33749179
Owner earnings: 13952.724885095231
Return on net tangible assets (%): 0.05020720810119892
Buffett classification: The Gruesome
Stock price: 8.68
P/E ratio: 1223.8442711555363
Shares outstanding: 174425914
Book value: 28974294.15627052
P/B ratio: 52.25379867251543
Market cap (USD): 1514016933.52
Debt to equity: 0.6789193219248162
Current ratio: 1.5956239849449616
Quick ratio: 1.4184914026449436
Effective tax rate (%): -287.64367816091954
Interest coverage ratio: -0.7030716723549487
COGS to revenue (%): 69.8239113079368
R&D to revenue (%): 23.57489669162135
SG&A to revenue (%): 6.911493716139204
Free cash flow (dilution-adjusted): -9455.022980958634
Buyback yield (%): 0
Retained earnings: 20932632.96126067
Inventory turnover: 1.0119266789402066
Receivables turnover: 0.9901315462400445
Capitalized R&D asset: 2753964.722395725
ROCI (R&D-adjusted, %): 0.6858780490525914
Rosenberg metric: -0.25600857352743694
FCF margin (%): -0.14460662479099826
Revenue growth (%): -11.450138311016605
Rule of 40 score: -11.594744935807604
Financial ratios for HIMX — annual report dated 2025-12-31
Total revenue: 26638060.179257363
Gross profit: 8142157.490396927
Operating income: 1412483.9948783612
Net income: 1449263.7644046096
Capital expenditures: 644206.1459667094
Operating cash flow: 4482298.33546735
Depreciation & amortization: 721798.9756722151
Net tangible assets: 27614884.7631242
Owner earnings: 1526856.5941101152
Return on net tangible assets (%): 5.529107244905173
Capex to operating income (%): 45.608031546027284
Buffett classification: The Good
Stock price: 8.05
P/E ratio: 968.8564926460077
Shares outstanding: 174425914
Book value: 28877688.860435344
P/B ratio: 48.623302733334874
Market cap (USD): 1404128607.7
Debt to equity: 0.6635252438925708
Current ratio: 1.5826363430555503
Quick ratio: 1.3916753907710857
Effective tax rate (%): 17.482275320320046
Interest coverage ratio: 12.639931251790319
COGS to revenue (%): 69.43412006878377
R&D to revenue (%): 19.362320094499584
SG&A to revenue (%): 5.901056631253357
Free cash flow (dilution-adjusted): 3802016.645326505
Buyback yield (%): 0.010292949492441842
Retained earnings: 20601408.450704228
Inventory turnover: 3.784588177501228
Receivables turnover: 4.132146581260241
Capitalized R&D asset: 10279082.813602572
ROCI (R&D-adjusted, %): 3.3777453870300067
Rosenberg metric: -0.05902812725456213
FCF margin (%): 14.27287354912981
Revenue growth (%): -3.764785314493001
Rule of 40 score: 10.50808823463681
Financial ratios for HIMX — quarterly report dated 2025-12-31
Total revenue: 6500672.215108835
Gross profit: 1975128.0409731115
Operating income: 218597.95134443024
Net income: 215556.97823303458
Capital expenditures: 127752.88092189502
Operating cash flow: 538060.1792573624
Depreciation & amortization: 215268.88604353394
Net tangible assets: 27614884.7631242
Owner earnings: 303072.9833546735
Return on net tangible assets (%): 1.0974986350817038
Capex to operating income (%): 58.44193879045248
Buffett classification: The Good
Stock price: 8.05
P/E ratio: 966.5938152612531
Shares outstanding: 174425914
Book value: 28877688.860435344
P/B ratio: 48.623302733334874
Market cap (USD): 1404128607.7
Debt to equity: 0.6635252438925708
Current ratio: 1.5826363430555503
Quick ratio: 1.3916753907710857
Effective tax rate (%): 20.137571157495255
Interest coverage ratio: 8.139451728247915
COGS to revenue (%): 69.61655694033416
R&D to revenue (%): 20.507580719023444
SG&A to revenue (%): 6.513164697829929
Free cash flow (dilution-adjusted): 405185.65941101155
Buyback yield (%): 0.0014362255105732802
Retained earnings: 20601408.450704228
Inventory turnover: 0.9260062223677747
Receivables turnover: 1.0083966433288645
Capitalized R&D asset: 2791770.0012879246
ROCI (R&D-adjusted, %): 0.49899353777690375
Rosenberg metric: 0.001350317942600509
FCF margin (%): 6.23298092879196
Revenue growth (%): -0.5776855547948032
Rule of 40 score: 5.655295373997157
Financial ratios for HIRECT.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.2125807727812212
Shares outstanding: 34372239
Market cap (USD): 41679116.128840834
Buyback yield (%): 0
Retained earnings: 3526097.850454965
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HIRECT.NS — annual report dated 2023-03-31
Total revenue: 43569707.67356882
Gross profit: 9363361.753958588
Operating income: 1423057.24725944
Net income: -775018.270401949
Capital expenditures: 3576138.8550548116
Operating cash flow: 4022570.036540804
Depreciation & amortization: 625931.790499391
Net tangible assets: 11110377.588306943
Owner earnings: -3725225.3349573696
Return on net tangible assets (%): -33.529241516309604
Capex to operating income (%): 251.29971840147905
Buffett classification: The Gruesome
Stock price: 1.1762484774665043
Shares outstanding: 34372239
Book value: 13607113.276492085
P/B ratio: 2.971261645974019
Market cap (USD): 40430293.7908648
Debt to equity: 0.9376741046812227
Current ratio: 1.2302990040271198
Quick ratio: 0.6173971042396806
Interest coverage ratio: 1.4371309781539068
COGS to revenue (%): 78.50946849561079
SG&A to revenue (%): 1.730660794454013
Free cash flow (dilution-adjusted): -912582.2168087699
Buyback yield (%): 0
Retained earnings: 2359208.282582217
Inventory turnover: 3.037936055316608
Receivables turnover: 5.29457483670337
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.259329062505744
FCF margin (%): -2.0945337151352517
Rule of 40 score: -2.0945337151352517
Financial ratios for HIRECT.NS — annual report dated 2024-03-31
Total revenue: 62002902.02662189
Gross profit: 15714258.30435304
Operating income: 5021069.672622616
Net income: 1500215.8532198104
Capital expenditures: 1644309.8692888836
Operating cash flow: 4064983.8110085144
Depreciation & amortization: 892936.8029739776
Net tangible assets: 12394004.077227484
Owner earnings: 748842.7869049045
Return on net tangible assets (%): 6.041976283361198
Capex to operating income (%): 32.748198620992724
Buffett classification: The Good
Stock price: 3.6098848368522076
P/E ratio: 82.70798106049611
Shares outstanding: 34372239
Book value: 14933385.297997363
P/B ratio: 8.308887897736073
Market cap (USD): 124079824.37476009
Debt to equity: 1.0847718813614444
Current ratio: 1.208396345733788
Quick ratio: 0.6490550019460349
Effective tax rate (%): 29.27638645485895
Interest coverage ratio: 3.290092171330237
COGS to revenue (%): 74.65560838167562
SG&A to revenue (%): 1.703845450139273
Free cash flow (dilution-adjusted): 2328900.3477635207
Buyback yield (%): 0
Retained earnings: 3822928.4086820963
Inventory turnover: 3.990957299969293
Receivables turnover: 5.799161265213144
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 26.482458431710615
FCF margin (%): 3.756115071458384
Revenue growth (%): 42.3073629301291
Rule of 40 score: 46.063478001587484
Financial ratios for HIRECT.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 14341232.680363115
Buffett classification: The Gruesome
Stock price: 5.317486860965122
Shares outstanding: 34372239
Book value: 16670879.120879125
P/B ratio: 10.96366471972922
Market cap (USD): 182773929.26445293
Debt to equity: 0.9240910921224399
Current ratio: 1.3128186867115124
Quick ratio: 0.6737055035549279
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HIRECT.NS — quarterly report dated 2025-03-31
Total revenue: 21633037.175590366
Gross profit: 5614683.189151274
Operating income: 2067220.0140285245
Net income: 1167991.5828852
Capital expenditures: 0
Depreciation & amortization: 258943.18447509935
Net tangible assets: 16240355.389291558
Owner earnings: 1426934.7673602994
Return on net tangible assets (%): 8.786351857183993
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 5.525615591084141
P/E ratio: 40.65264307164491
Shares outstanding: 34372239
Book value: 18689501.987374324
P/B ratio: 10.162270768219287
Market cap (USD): 189927779.71887037
Debt to equity: 1.0275035966722963
Current ratio: 1.2223880528684379
Quick ratio: 0.6696546703963301
Effective tax rate (%): 28.661192431274547
Interest coverage ratio: 4.399850709131625
COGS to revenue (%): 74.04579327637545
Buyback yield (%): 0
Retained earnings: 7824994.154781388
Inventory turnover: 1.1349092625876935
Receivables turnover: 1.6891738931994524
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.89223017313775
Rule of 40 score: 0
Financial ratios for HIRECT.NS — annual report dated 2025-03-31
Total revenue: 76484101.00537759
Gross profit: 20309328.968903437
Operating income: 7826280.102875847
Net income: 4338671.966331541
Capital expenditures: 2509352.3497778815
Operating cash flow: 4164718.260462941
Depreciation & amortization: 992167.407061024
Net tangible assets: 16240355.389291558
Owner earnings: 2821487.0236146827
Return on net tangible assets (%): 17.37330837892312
Capex to operating income (%): 32.06315537896215
Buffett classification: The Good
Stock price: 5.525615591084141
P/E ratio: 43.77555648196635
Shares outstanding: 34372239
Book value: 18689501.987374324
P/B ratio: 10.162270768219287
Market cap (USD): 189927779.71887037
Debt to equity: 1.0275035966722963
Current ratio: 1.2223880528684379
Quick ratio: 0.6696546703963301
Effective tax rate (%): 25.94137249815417
Interest coverage ratio: 5.074742268041238
COGS to revenue (%): 73.44633890973566
SG&A to revenue (%): 1.193589557428792
Free cash flow (dilution-adjusted): 1499999.9999999998
Buyback yield (%): 0
Retained earnings: 7824994.154781388
Inventory turnover: 3.980013749347734
Receivables turnover: 5.972113190324053
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 33.66505916252219
FCF margin (%): 1.9611919082300973
Revenue growth (%): 23.355679339876662
Rule of 40 score: 25.31687124810676
Financial ratios for HIRECT.NS — quarterly report dated 2025-06-30
Total revenue: 25131523.519775335
Gross profit: 6579218.347765037
Operating income: 2515913.877837585
Net income: 1493681.2543880178
Capital expenditures: 0
Depreciation & amortization: 319096.65340510185
Owner earnings: 1812777.9077931195
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 7.484086122162416
P/E ratio: 43.055503999236194
Shares outstanding: 34372239
Market cap (USD): 257244796.88754976
Effective tax rate (%): 29.49072028281043
Interest coverage ratio: 5.932947019867549
COGS to revenue (%): 73.8208535483811
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 16.171961041755548
Rule of 40 score: 16.171961041755548
Financial ratios for HIRECT.NS — quarterly report dated 2025-09-30
Total revenue: 25608455.467869222
Gross profit: 6490868.09470124
Operating income: 2602142.051860203
Net income: 1659977.452085682
Capital expenditures: 0
Depreciation & amortization: 316347.237880496
Net tangible assets: 19094137.54227734
Owner earnings: 1976324.689966178
Return on net tangible assets (%): 10.350426593452012
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 9.177001127395716
P/E ratio: 72.98926450175783
Shares outstanding: 34372239
Book value: 21443404.73506201
P/B ratio: 14.710074260658345
Market cap (USD): 315434076.054115
Debt to equity: 1.091870264927472
Current ratio: 1.2630607835886258
Quick ratio: 0.7070709823079468
Effective tax rate (%): 25.041999694547677
Interest coverage ratio: 6.47615039281706
COGS to revenue (%): 74.6534182709875
Buyback yield (%): 0
Inventory turnover: 1.1872282627720874
Receivables turnover: 2.23607296496461
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.321137226395281
Revenue growth (%): 1.8977438742167867
Rule of 40 score: 1.8977438742167867
Financial ratios for HIRECT.NS — quarterly report dated 2025-12-31
Total revenue: 30899966.58126323
Gross profit: 8726523.337417847
Operating income: 2349559.9866325054
Net income: 1414392.3359697005
Capital expenditures: 0
Depreciation & amortization: 495377.0747465746
Owner earnings: 1909769.4107162752
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 8.414837919126658
P/E ratio: 50.424454453197974
Shares outstanding: 34372239
Market cap (USD): 289236820.10248417
Effective tax rate (%): 17.11058884971928
Interest coverage ratio: 4.481937951551211
COGS to revenue (%): 71.75879360753311
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 20.663140422635934
Rule of 40 score: 20.663140422635934
Financial ratios for HSHP — annual report dated 2023-12-31
Total revenue: 36700000
Gross profit: 18400000
Operating income: 14600000
Net income: 1500000
Capital expenditures: 413000000
Operating cash flow: 6400000
Depreciation & amortization: 9100000
Net tangible assets: 154205000
Owner earnings: -402400000
Return on net tangible assets (%): -260.95133102039495
Capex to operating income (%): 2828.767123287671
Buffett classification: The Gruesome
Stock price: 5.95
P/E ratio: 187.00850000000003
Shares outstanding: 47145000
Book value: 154205000
P/B ratio: 1.8190898479297042
Market cap (USD): 280512750
Debt to equity: 2.850076197269868
Current ratio: 1.2967193675889328
Quick ratio: 1.2716600790513835
Effective tax rate (%): 0
Interest coverage ratio: 1.0735294117647058
COGS to revenue (%): 49.863760217983646
SG&A to revenue (%): 10.354223433242508
Free cash flow (dilution-adjusted): -407100000
Buyback yield (%): 0
Retained earnings: -1483000
Inventory turnover: 28.86435331230284
Receivables turnover: 45.252774352651045
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.5439706153969466
FCF margin (%): -1109.2643051771117
Rule of 40 score: -1109.2643051771117
Financial ratios for HSHP — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 7.94
Shares outstanding: 47145000
Market cap (USD): 374331300
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HSHP — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.55
Shares outstanding: 47145000
Market cap (USD): 214509750
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HSHP — annual report dated 2024-12-31
Total revenue: 123600000
Gross profit: 71700000
Operating income: 66700000
Net income: 21100000
Capital expenditures: 313100000
Operating cash flow: 55900000
Depreciation & amortization: 26500000
Net tangible assets: 154700000
Owner earnings: -265500000
Return on net tangible assets (%): -171.62249515190692
Capex to operating income (%): 469.4152923538231
Buffett classification: The Gruesome
Stock price: 4.55
P/E ratio: 10.166338862559241
Shares outstanding: 47145000
Book value: 154700000
P/B ratio: 1.3866176470588234
Market cap (USD): 214509750
Debt to equity: 4.614738202973497
Current ratio: 0.7486033519553073
Quick ratio: 0.7067039106145251
Effective tax rate (%): 0
Interest coverage ratio: 1.4313304721030042
COGS to revenue (%): 41.99029126213592
SG&A to revenue (%): 4.0453074433656955
Free cash flow (dilution-adjusted): -257700000
Buyback yield (%): 0
Retained earnings: 19600000
Inventory turnover: 34.6
Receivables turnover: 103
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.900035532393698
FCF margin (%): -208.49514563106797
Revenue growth (%): 236.78474114441417
Rule of 40 score: 28.2895955133462
Financial ratios for HSHP — quarterly report dated 2025-03-31
Total revenue: 22000000
Gross profit: 7600000
Operating income: 6500000
Net income: -6400000
Capital expenditures: 0
Operating cash flow: 300000
Depreciation & amortization: 7300000
Net tangible assets: 162549000
Owner earnings: 900000
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 5.14
Shares outstanding: 47145000
Book value: 162549000
P/B ratio: 1.49078308694609
Market cap (USD): 242325299.99999997
Debt to equity: 4.355222117638374
Current ratio: 1.0024581963698729
Quick ratio: 0.9554380448763756
Interest coverage ratio: 0.4961832061068702
COGS to revenue (%): 65.45454545454545
SG&A to revenue (%): 5
Free cash flow (dilution-adjusted): 300000
Buyback yield (%): 0
Retained earnings: 13187000
Inventory turnover: 8.753799392097264
Receivables turnover: 30.985915492957748
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.7682198101433381
FCF margin (%): 1.3636363636363635
Rule of 40 score: 1.3636363636363635
Financial ratios for HSHP — quarterly report dated 2025-06-30
Total revenue: 29900000
Gross profit: 15100000
Operating income: 13600000
Net income: 1100000
Capital expenditures: 0
Operating cash flow: 8300000
Depreciation & amortization: 7300000
Net tangible assets: 159300000
Owner earnings: 8400000
Return on net tangible assets (%): 5.273069679849341
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 5.51
P/E ratio: 59.038397727272724
Shares outstanding: 47145000
Book value: 159300000
P/B ratio: 1.6306902071563087
Market cap (USD): 259768950
Debt to equity: 4.402385436283741
Current ratio: 0.9457142857142857
Quick ratio: 0.9
Effective tax rate (%): 0
Interest coverage ratio: 1.0625
COGS to revenue (%): 49.49832775919732
SG&A to revenue (%): 5.016722408026756
Free cash flow (dilution-adjusted): 8200000
Buyback yield (%): 0
Retained earnings: 14300000
Inventory turnover: 9.25
Receivables turnover: 74.75
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.625044808220815
FCF margin (%): 27.424749163879596
Revenue growth (%): 35.90909090909091
Rule of 40 score: 63.3338400729705
Financial ratios for HSHP — quarterly report dated 2025-09-30
Total revenue: 37900000
Gross profit: 23100000
Operating income: 22000000
Net income: 9500000
Capital expenditures: 0
Operating cash flow: 18300000
Depreciation & amortization: 7300000
Net tangible assets: 160100000
Owner earnings: 16800000
Return on net tangible assets (%): 10.493441599000624
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 7.91
P/E ratio: 88.78975
Shares outstanding: 47145000
Book value: 160100000
P/B ratio: 2.329275140537164
Market cap (USD): 372916950
Debt to equity: 4.343535290443473
Current ratio: 1.005952380952381
Quick ratio: 0.9583333333333334
Effective tax rate (%): 0
Interest coverage ratio: 1.71875
COGS to revenue (%): 39.050131926121374
SG&A to revenue (%): 2.9023746701846966
Free cash flow (dilution-adjusted): 18200000
Buyback yield (%): 0
Retained earnings: 23800000
Inventory turnover: 9.25
Receivables turnover: 75.8
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.6451845617410124
FCF margin (%): 48.02110817941953
Revenue growth (%): 26.755852842809364
Rule of 40 score: 74.77696102222889
Financial ratios for HSHP — quarterly report dated 2025-12-31
Total revenue: 42100000
Gross profit: 27200000
Operating income: 26000000
Net income: 13500000
Capital expenditures: 0
Operating cash flow: 24700000
Depreciation & amortization: 7300000
Net tangible assets: 161700000
Owner earnings: 20800000
Return on net tangible assets (%): 12.863327149041433
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 8.75
P/E ratio: 23.30614406779661
Shares outstanding: 47145000
Book value: 161700000
P/B ratio: 2.5511363636363638
Market cap (USD): 412518750
Debt to equity: 4.262213976499691
Current ratio: 1.0846994535519126
Quick ratio: 1.0382513661202186
Effective tax rate (%): 0
Interest coverage ratio: 2.047244094488189
COGS to revenue (%): 35.39192399049881
SG&A to revenue (%): 2.8503562945368173
Free cash flow (dilution-adjusted): 24700000
Buyback yield (%): 0
Retained earnings: 37300000
Inventory turnover: 8.764705882352942
Receivables turnover: 60.142857142857146
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.1427535355977274
FCF margin (%): 58.66983372921615
Revenue growth (%): 11.081794195250659
Rule of 40 score: 69.75162792446682
Financial ratios for HSHP — annual report dated 2025-12-31
Total revenue: 131900000
Gross profit: 73100000
Operating income: 68200000
Net income: 17700000
Capital expenditures: 0
Operating cash flow: 51700000
Depreciation & amortization: 29200000
Net tangible assets: 161700000
Owner earnings: 46900000
Return on net tangible assets (%): 29.004329004329005
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 8.75
P/E ratio: 23.30614406779661
Shares outstanding: 47145000
Book value: 161700000
P/B ratio: 2.5511363636363638
Market cap (USD): 412518750
Debt to equity: 4.262213976499691
Current ratio: 1.0846994535519126
Quick ratio: 1.0382513661202186
Effective tax rate (%): 0
Interest coverage ratio: 1.3268482490272373
COGS to revenue (%): 44.579226686884006
SG&A to revenue (%): 3.7149355572403335
Free cash flow (dilution-adjusted): 51500000
Buyback yield (%): 0
Retained earnings: 37300000
Inventory turnover: 34.588235294117645
Receivables turnover: 188.42857142857142
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.243684274144808
FCF margin (%): 39.044730856709634
Revenue growth (%): 6.715210355987054
Rule of 40 score: 45.75994121269669
Financial ratios for IMM.L — annual report dated 2021-12-31
Total revenue: 159932.43243243243
Operating income: -6972798.6486486485
Net income: -11045817.567567568
Capital expenditures: 68829.72972972973
Operating cash flow: -6531313.513513514
Depreciation & amortization: 154214.86486486485
Net tangible assets: 5318843.243243244
Owner earnings: -10960432.432432434
Return on net tangible assets (%): -206.06797251180402
Buffett classification: The Gruesome
Stock price: 0.000945945945945946
Shares outstanding: 623911379
Book value: 5964185.135135135
P/B ratio: 0.09895508375784555
Market cap (USD): 590186.4395945946
Debt to equity: 0.0001586043901242031
Current ratio: 2.1119229642795827
Quick ratio: 2.1119229642795827
Interest coverage ratio: -41.590732128031725
COGS to revenue (%): 0
R&D to revenue (%): 3084.410646387833
SG&A to revenue (%): 854.5821715251373
Free cash flow (dilution-adjusted): -7433147.297297298
Buyback yield (%): 0
Retained earnings: -76461666.21621622
Capitalized R&D asset: 4932972.972972973
ROCI (R&D-adjusted, %): -33.80835593510185
FCF margin (%): -4647.679763413604
Rule of 40 score: -4647.679763413604
Financial ratios for IMM.L — annual report dated 2022-12-31
Total revenue: 0
Operating income: -3649339.7590361447
Net income: -4587266.265060241
Capital expenditures: 127721.68674698795
Operating cash flow: -2827789.1566265062
Depreciation & amortization: 141642.1686746988
Net tangible assets: 2469259.0361445784
Owner earnings: -4573345.78313253
Return on net tangible assets (%): -185.21126038980523
Buffett classification: The Gruesome
Stock price: 0.00024096385542168676
Shares outstanding: 623911379
Book value: 3040213.2530120485
P/B ratio: 0.04945050850507078
Market cap (USD): 150340.0913253012
Debt to equity: 4.398867073766622e-05
Current ratio: 1.6115980993906254
Quick ratio: 1.6115980993906254
Interest coverage ratio: -1487.6974459724952
Free cash flow (dilution-adjusted): -3148130.120481928
Buyback yield (%): 0
Retained earnings: -73632915.6626506
Receivables turnover: 0
Capitalized R&D asset: 5741847.313578639
ROCI (R&D-adjusted, %): -41.780177226983696
Revenue growth (%): -100
Rule of 40 score: -100
Financial ratios for IMM.L — annual report dated 2023-12-31
Total revenue: 0
Operating income: -3877224.0506329113
Net income: -3698474.6835443038
Capital expenditures: 235110.12658227846
Operating cash flow: -1727097.4683544303
Depreciation & amortization: 47603.79746835443
Net tangible assets: 770529.1139240506
Owner earnings: -3885981.0126582277
Return on net tangible assets (%): -504.3263054485
Buffett classification: The Gruesome
Stock price: 0.00025316455696202533
Shares outstanding: 623911379
Book value: 1337074.6835443038
P/B ratio: 0.11813270402323607
Market cap (USD): 157952.24784810128
Debt to equity: 0
Current ratio: 0.8066670189932029
Quick ratio: 0.8066670189932029
Interest coverage ratio: -1542.299597180262
Free cash flow (dilution-adjusted): -1904613.9240506329
Buyback yield (%): 0
Retained earnings: -81117610.12658228
Capitalized R&D asset: 5820386.960446645
ROCI (R&D-adjusted, %): -64.6488086761965
Rule of 40 score: 0
Financial ratios for IMM.L — annual report dated 2024-12-31
Total revenue: 0
Operating income: -2839011.25
Net income: -3104373.75
Capital expenditures: 2065
Operating cash flow: -2211381.25
Depreciation & amortization: 79850
Net tangible assets: -690851.25
Owner earnings: -3026588.75
Buffett classification: The Gruesome
Stock price: 0.000125
Shares outstanding: 623911379
Book value: -678573.75
Market cap (USD): 77988.922375
Debt to equity: 0
Current ratio: 0.5821997934033832
Quick ratio: 0.5821997934033832
Interest coverage ratio: -1144.7626008064517
Free cash flow (dilution-adjusted): -2323080
Buyback yield (%): 0
Retained earnings: -82388928.75
Capitalized R&D asset: 3971179.969536373
ROCI (R&D-adjusted, %): -107.41041909364371
Rule of 40 score: 0
Financial ratios for IMM.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -690851.25
Buffett classification: The Gruesome
Stock price: 0.000125
Shares outstanding: 623911379
Book value: -678573.75
Market cap (USD): 77988.922375
Debt to equity: 0
Current ratio: 0.5821997934033832
Quick ratio: 0.5821997934033832
Buyback yield (%): 0
Retained earnings: -82388928.75
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IMM.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 454378.08219178085
Buffett classification: The Gruesome
Stock price: 0.00027397260273972606
Shares outstanding: 623911379
Book value: 461231.506849315
P/B ratio: 0.3706048304271769
Market cap (USD): 170934.62438356166
Debt to equity: 0
Current ratio: 1.2069095235033118
Quick ratio: 1.2069095235033118
Buyback yield (%): 0
Retained earnings: -92808243.83561644
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IRD — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.73
Shares outstanding: 82565835
Market cap (USD): 307970564.55
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IRD — annual report dated 2022-12-31
Total revenue: 39850000
Operating income: 18226000
Net income: 17888000
Capital expenditures: 0
Operating cash flow: 14314000
Depreciation & amortization: 4000
Net tangible assets: 46239000
Owner earnings: 17892000
Return on net tangible assets (%): 38.69460844741452
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.53
P/E ratio: 16.293459165362254
Shares outstanding: 82565835
Book value: 46239000
P/B ratio: 6.303280727308117
Market cap (USD): 291457397.55
Debt to equity: 0
Current ratio: 17.793679622230293
Quick ratio: 17.793679622230293
Effective tax rate (%): 1.7304839861561279
Interest coverage ratio: 2025.111111111111
COGS to revenue (%): 0
R&D to revenue (%): 36.022584692597235
SG&A to revenue (%): 18.240903387703888
Free cash flow (dilution-adjusted): 12507000
Buyback yield (%): 0
Retained earnings: -71480000
Receivables turnover: 8.216494845360824
Capitalized R&D asset: 14355000
ROCI (R&D-adjusted, %): 45.87252863319801
FCF margin (%): 31.38519447929736
Rule of 40 score: 31.38519447929736
Financial ratios for IRD — annual report dated 2023-12-31
Total revenue: 19049000
Operating income: -10563000
Net income: -9986000
Capital expenditures: 0
Operating cash flow: -1112000
Depreciation & amortization: 6000
Net tangible assets: 49906000
Owner earnings: -9980000
Return on net tangible assets (%): -19.997595479501463
Buffett classification: The Gruesome
Stock price: 3.01
Shares outstanding: 82565835
Book value: 49906000
P/B ratio: 4.979825338636636
Market cap (USD): 248523163.35
Debt to equity: 0
Current ratio: 13.346857991093518
Quick ratio: 13.346857991093518
Interest coverage ratio: -7.954066265060241
COGS to revenue (%): 0
R&D to revenue (%): 92.67153131397974
SG&A to revenue (%): 62.78019843561342
Free cash flow (dilution-adjusted): -4622000
Buyback yield (%): 0
Retained earnings: -81466000
Receivables turnover: 8.165023574796399
Capitalized R&D asset: 27270850
ROCI (R&D-adjusted, %): -4.6378328907351545
FCF margin (%): -24.263740878786287
Revenue growth (%): -52.19824341279799
Rule of 40 score: -76.46198429158429
Financial ratios for IRD — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.31
Shares outstanding: 82565835
Market cap (USD): 108161243.85000001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IRD — annual report dated 2024-12-31
Total revenue: 10992000
Operating income: -34074000
Net income: -57532000
Capital expenditures: 0
Operating cash flow: -25576000
Depreciation & amortization: 10000
Net tangible assets: 6724000
Owner earnings: -57522000
Return on net tangible assets (%): -855.4729327781082
Buffett classification: The Gruesome
Stock price: 1.19
Shares outstanding: 82565835
Book value: 6724000
P/B ratio: 14.612335462522308
Market cap (USD): 98253343.64999999
Debt to equity: 0
Current ratio: 3.2412571934484284
Quick ratio: 3.2412571934484284
COGS to revenue (%): 0
R&D to revenue (%): 244.27765647743814
SG&A to revenue (%): 165.71142649199416
Free cash flow (dilution-adjusted): -28938000
Buyback yield (%): 0.08040438835487917
Retained earnings: -138998000
Receivables turnover: 1.9043659043659045
Capitalized R&D asset: 43415660
ROCI (R&D-adjusted, %): -38.91219426253883
FCF margin (%): -263.264192139738
Revenue growth (%): -42.296183526694314
Rule of 40 score: -305.5603756664323
Financial ratios for IRD — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.19
Shares outstanding: 82565835
Market cap (USD): 98253343.64999999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IRD — quarterly report dated 2025-03-31
Total revenue: 4370000
Operating income: -9929000
Net income: -8194000
Capital expenditures: 0
Operating cash flow: -8994000
Depreciation & amortization: 13000
Net tangible assets: 5073000
Owner earnings: -8181000
Return on net tangible assets (%): -161.2655233589592
Buffett classification: The Gruesome
Stock price: 0.98
Shares outstanding: 82565835
Book value: 5073000
P/B ratio: 15.950033175635717
Market cap (USD): 80914518.3
Debt to equity: 0
Current ratio: 1.9763308729536926
Quick ratio: 1.9763308729536926
Interest coverage ratio: -7.236880466472303
COGS to revenue (%): 0
R&D to revenue (%): 181.9908466819222
SG&A to revenue (%): 145.21739130434784
Free cash flow (dilution-adjusted): -9907000
Buyback yield (%): 0.044491397534526266
Retained earnings: -147192000
Receivables turnover: 0.9190325972660357
Capitalized R&D asset: 7953000
ROCI (R&D-adjusted, %): -14.518811384103675
FCF margin (%): -226.70480549199087
Rule of 40 score: -226.70480549199087
Financial ratios for IRD — quarterly report dated 2025-06-30
Total revenue: 2882000
Operating income: -8906000
Net income: -7420000
Capital expenditures: 0
Operating cash flow: -10269000
Depreciation & amortization: 14000
Net tangible assets: 17473000
Owner earnings: -7406000
Return on net tangible assets (%): -42.385394608825045
Buffett classification: The Gruesome
Stock price: 0.94
Shares outstanding: 82565835
Book value: 17473000
P/B ratio: 4.441817941967607
Market cap (USD): 77611884.89999999
Debt to equity: 0.05723115664167573
Current ratio: 1.9036747226624406
Quick ratio: 1.9036747226624406
COGS to revenue (%): 0
R&D to revenue (%): 208.95211658570437
SG&A to revenue (%): 200.06939625260233
Free cash flow (dilution-adjusted): -11165000
Buyback yield (%): 0
Retained earnings: -154612000
Receivables turnover: 0.6296700895783264
Capitalized R&D asset: 11350510
ROCI (R&D-adjusted, %): -25.289891543058925
FCF margin (%): -387.40458015267177
Revenue growth (%): -34.05034324942792
Rule of 40 score: -421.45492340209967
Financial ratios for IRD — quarterly report dated 2025-09-30
Total revenue: 3079000
Operating income: -8311000
Net income: -17454000
Capital expenditures: 0
Operating cash flow: -6157000
Depreciation & amortization: 13000
Net tangible assets: 5967000
Owner earnings: -17441000
Return on net tangible assets (%): -292.29093346740405
Buffett classification: The Gruesome
Stock price: 1.65
Shares outstanding: 82565835
Book value: 5967000
P/B ratio: 22.831176093514326
Market cap (USD): 136233627.75
Debt to equity: 0.17898441427853193
Current ratio: 1.2345721456320693
Quick ratio: 1.2345721456320693
Interest coverage ratio: -122.22058823529412
COGS to revenue (%): 0
R&D to revenue (%): 208.15199740175382
SG&A to revenue (%): 161.77330302046119
Free cash flow (dilution-adjusted): -6973000
Buyback yield (%): 0
Retained earnings: -172066000
Receivables turnover: 0.719392523364486
Capitalized R&D asset: 13068230
ROCI (R&D-adjusted, %): -43.260046602793025
FCF margin (%): -226.46963299772653
Revenue growth (%): 6.835530881332408
Rule of 40 score: -219.63410211639413
Financial ratios for IRD — annual report dated 2025-12-31
Total revenue: 14196000
Operating income: -38599000
Net income: -49591000
Capital expenditures: 0
Operating cash flow: -35253000
Depreciation & amortization: 53000
Net tangible assets: 15348000
Owner earnings: -49538000
Return on net tangible assets (%): -322.765181131092
Buffett classification: The Gruesome
Stock price: 2.01
Shares outstanding: 82565835
Book value: 15348000
P/B ratio: 10.81296119038311
Market cap (USD): 165957328.35
Debt to equity: 0.07356007297367735
Current ratio: 6.431564066315383
Quick ratio: 6.431564066315383
Interest coverage ratio: -26.329467939972716
COGS to revenue (%): 0
R&D to revenue (%): 217.04705550859398
SG&A to revenue (%): 154.85347985347985
Free cash flow (dilution-adjusted): -38652000
Buyback yield (%): 0.09158980896549243
Retained earnings: -188589000
Receivables turnover: 4.485308056872038
Capitalized R&D asset: 54627660
ROCI (R&D-adjusted, %): -33.87830726086932
FCF margin (%): -272.2738799661876
Revenue growth (%): 29.148471615720524
Rule of 40 score: -243.1254083504671
Financial ratios for IRD — quarterly report dated 2025-12-31
Total revenue: 3865000
Operating income: -11453000
Net income: -16523000
Capital expenditures: 0
Operating cash flow: -9833000
Depreciation & amortization: 13000
Net tangible assets: 15348000
Owner earnings: -16510000
Return on net tangible assets (%): -107.57101902528017
Buffett classification: The Gruesome
Stock price: 2.01
Shares outstanding: 82565835
Book value: 15348000
P/B ratio: 10.81296119038311
Market cap (USD): 165957328.35
Debt to equity: 0.07356007297367735
Current ratio: 6.431564066315383
Quick ratio: 6.431564066315383
Interest coverage ratio: -8.19241773962804
COGS to revenue (%): 0
R&D to revenue (%): 269.8059508408797
SG&A to revenue (%): 126.52005174644243
Free cash flow (dilution-adjusted): -10607000
Buyback yield (%): 0.06989748578945475
Retained earnings: -188589000
Receivables turnover: 1.221169036334913
Capitalized R&D asset: 16709290
ROCI (R&D-adjusted, %): -14.60956262178274
FCF margin (%): -274.4372574385511
Revenue growth (%): 25.527768756089642
Rule of 40 score: -248.90948868246147
Financial ratios for ITU.DE — annual report dated 2021-07-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 507.9404761904762
Shares outstanding: 273537000
Market cap (USD): 138940514035.7143
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ITU.DE — annual report dated 2022-07-31
Total revenue: 12726000000
Gross profit: 10320000000
Operating income: 2559000000
Net income: 2066000000
Capital expenditures: 157000000
Operating cash flow: 3889000000
Depreciation & amortization: 746000000
Net tangible assets: -4356000000
Owner earnings: 2655000000
Return on net tangible assets (%): -60.9504132231405
Capex to operating income (%): 6.135209066041422
Buffett classification: The Great
Stock price: 434.295918367347
P/E ratio: 57.50048529644191
Shares outstanding: 273537000
Book value: 16441000000
P/B ratio: 7.225594709716501
Market cap (USD): 118796002622.44899
Debt to equity: 0.45860957362690835
Current ratio: 1.390358126721763
Quick ratio: 1.390358126721763
Effective tax rate (%): 18.72541306058222
Interest coverage ratio: 31.59259259259259
COGS to revenue (%): 18.906176331918907
R&D to revenue (%): 18.442558541568445
SG&A to revenue (%): 39.273927392739274
Free cash flow (dilution-adjusted): 2352000000
Buyback yield (%): 1.566551027743357
Retained earnings: 13581000000
Receivables turnover: 8.60446247464503
Capitalized R&D asset: 2347000000
ROCI (R&D-adjusted, %): 15.589832772547982
FCF margin (%): 18.48184818481848
Rule of 40 score: 18.48184818481848
Financial ratios for ITU.DE — annual report dated 2023-07-31
Total revenue: 14368000000
Gross profit: 11225000000
Operating income: 3141000000
Net income: 2384000000
Capital expenditures: 210000000
Operating cash flow: 5046000000
Depreciation & amortization: 806000000
Net tangible assets: -2930000000
Owner earnings: 2980000000
Return on net tangible assets (%): -101.70648464163823
Capex to operating income (%): 6.685768863419293
Buffett classification: The Great
Stock price: 495.1868131868132
P/E ratio: 56.81707857327237
Shares outstanding: 273537000
Book value: 17269000000
P/B ratio: 7.843645568283127
Market cap (USD): 135451915318.68132
Debt to equity: 0.38734147895072096
Current ratio: 1.46622691292876
Quick ratio: 1.46622691292876
Effective tax rate (%): 20.24088323854132
Interest coverage ratio: 12.665322580645162
COGS to revenue (%): 21.875
R&D to revenue (%): 17.67121380846325
SG&A to revenue (%): 35.23106904231626
Free cash flow (dilution-adjusted): 3074000000
Buyback yield (%): 1.4521758480654827
Retained earnings: 15067000000
Receivables turnover: 9.323815704088254
Capitalized R&D asset: 4111490000
ROCI (R&D-adjusted, %): 14.416791897274248
Rosenberg metric: 0.3855986365573072
FCF margin (%): 21.39476614699332
Revenue growth (%): 12.902718843312902
Rule of 40 score: 34.29748499030622
Financial ratios for ITU.DE — annual report dated 2024-07-31
Total revenue: 16285000000
Gross profit: 12820000000
Operating income: 3853000000
Net income: 2963000000
Capital expenditures: 191000000
Operating cash flow: 4884000000
Depreciation & amortization: 789000000
Net tangible assets: -1228000000
Owner earnings: 3561000000
Return on net tangible assets (%): -289.98371335504885
Capex to operating income (%): 4.957176226317155
Buffett classification: The Great
Stock price: 642.1847826086955
P/E ratio: 59.28494731030535
Shares outstanding: 273537000
Book value: 18436000000
P/B ratio: 9.52816765461243
Market cap (USD): 175661298880.43475
Debt to equity: 0.3562052505966587
Current ratio: 1.2919503404084902
Quick ratio: 1.2919503404084902
Effective tax rate (%): 16.535211267605636
Interest coverage ratio: 15.921487603305785
COGS to revenue (%): 21.27724900214922
R&D to revenue (%): 16.911268038071846
SG&A to revenue (%): 35.185753761129874
Free cash flow (dilution-adjusted): 2694000000
Buyback yield (%): 1.1317233862383929
Retained earnings: 16989000000
Receivables turnover: 3.110792741165234
Capitalized R&D asset: 5229640000
ROCI (R&D-adjusted, %): 13.59305770928689
Rosenberg metric: 0.6282000787711698
FCF margin (%): 16.54283082591342
Revenue growth (%): 13.342149220489977
Rule of 40 score: 29.8849800464034
Financial ratios for ITU.DE — quarterly report dated 2024-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 600.9891304347825
Shares outstanding: 273537000
Market cap (USD): 164392763771.7391
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ITU.DE — quarterly report dated 2025-01-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 600.3958333333334
Shares outstanding: 273537000
Market cap (USD): 164230475062.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ITU.DE — quarterly report dated 2025-04-30
Total revenue: 7754000000
Gross profit: 6560000000
Operating income: 3721000000
Net income: 2820000000
Capital expenditures: 35000000
Operating cash flow: 4395000000
Depreciation & amortization: 201000000
Net tangible assets: 881000000
Owner earnings: 2986000000
Return on net tangible assets (%): 338.93303064699205
Capex to operating income (%): 0.9406073636119323
Buffett classification: The Great
Stock price: 614.3977272727273
P/E ratio: 14.898981482712765
Shares outstanding: 273537000
Book value: 20125000000
P/B ratio: 8.350832850931676
Market cap (USD): 168060511125
Debt to equity: 0.3521490683229814
Current ratio: 1.4465506525792418
Quick ratio: 1.4465506525792418
Effective tax rate (%): 23.452768729641694
Interest coverage ratio: 54.720588235294116
COGS to revenue (%): 15.39850399793655
R&D to revenue (%): 9.117874645344338
SG&A to revenue (%): 25.947897859169462
Free cash flow (dilution-adjusted): 3891000000
Buyback yield (%): 0.4474578798827272
Retained earnings: 19586000000
Receivables turnover: 1.072179203539823
Capitalized R&D asset: 707000000
ROCI (R&D-adjusted, %): 15.164339627191397
FCF margin (%): 50.180551973175135
Rule of 40 score: 50.180551973175135
Financial ratios for ITU.DE — annual report dated 2025-07-31
Total revenue: 18831000000
Gross profit: 14983000000
Operating income: 4938000000
Net income: 3869000000
Capital expenditures: 84000000
Operating cash flow: 6207000000
Depreciation & amortization: 809000000
Net tangible assets: 428000000
Owner earnings: 4594000000
Return on net tangible assets (%): 1073.3644859813085
Capex to operating income (%): 1.701093560145808
Buffett classification: The Great
Stock price: 790.0574712643678
P/E ratio: 55.856797755813226
Shares outstanding: 273537000
Book value: 19710000000
P/B ratio: 10.964482522437411
Market cap (USD): 216109950517.24136
Debt to equity: 0.33683409436834094
Current ratio: 1.3603664416586307
Quick ratio: 1.3603664416586307
Effective tax rate (%): 19.962763756723213
Interest coverage ratio: 19.991902834008098
COGS to revenue (%): 20.434390101428495
R&D to revenue (%): 15.54882905846742
SG&A to revenue (%): 35.23976421857575
Free cash flow (dilution-adjusted): 4115000000
Buyback yield (%): 1.282680410302925
Retained earnings: 19668000000
Receivables turnover: 2.0787062589689813
Capitalized R&D asset: 5611050000
ROCI (R&D-adjusted, %): 15.918689112463461
Rosenberg metric: 0.7854030501089324
FCF margin (%): 21.852264882374808
Revenue growth (%): 15.634019035922627
Rule of 40 score: 37.48628391829743
Financial ratios for ITU.DE — quarterly report dated 2025-07-31
Total revenue: 3831000000
Gross profit: 2937000000
Operating income: 340000000
Net income: 381000000
Capital expenditures: 15000000
Operating cash flow: 381000000
Depreciation & amortization: 208000000
Net tangible assets: 428000000
Owner earnings: 574000000
Return on net tangible assets (%): 134.11214953271028
Capex to operating income (%): 4.411764705882353
Buffett classification: The Great
Stock price: 790.0574712643678
P/E ratio: 67.51326164237469
Shares outstanding: 273537000
Book value: 19710000000
P/B ratio: 10.964482522437411
Market cap (USD): 216109950517.24136
Debt to equity: 0.33683409436834094
Current ratio: 1.3603664416586307
Quick ratio: 1.3603664416586307
Effective tax rate (%): -4.098360655737705
Interest coverage ratio: 5.762711864406779
COGS to revenue (%): 23.335943617854348
R&D to revenue (%): 20.90837901331245
SG&A to revenue (%): 43.72226572696424
Free cash flow (dilution-adjusted): -134000000
Buyback yield (%): 0.34519465587517395
Retained earnings: 19668000000
Receivables turnover: 0.42289435920079477
Capitalized R&D asset: 1274690000
ROCI (R&D-adjusted, %): 2.290996789374369
Rosenberg metric: -5.124469589816124
FCF margin (%): -3.497781258157139
Revenue growth (%): -50.59324219757545
Rule of 40 score: -54.09102345573259
Financial ratios for ITU.DE — quarterly report dated 2025-10-31
Total revenue: 3885000000
Gross profit: 3002000000
Operating income: 534000000
Net income: 446000000
Capital expenditures: 38000000
Operating cash flow: 637000000
Depreciation & amortization: 209000000
Net tangible assets: 206000000
Owner earnings: 617000000
Return on net tangible assets (%): 299.5145631067961
Capex to operating income (%): 7.116104868913857
Buffett classification: The Great
Stock price: 662.0697674418604
P/E ratio: 49.65741101638173
Shares outstanding: 273537000
Book value: 19322000000
P/B ratio: 9.37276565452563
Market cap (USD): 181100577976.74417
Debt to equity: 0.3550874650657282
Current ratio: 1.3859555791993616
Quick ratio: 1.3859555791993616
Effective tax rate (%): 20.499108734402853
Interest coverage ratio: 9.206896551724139
COGS to revenue (%): 22.728442728442726
R&D to revenue (%): 21.698841698841697
SG&A to revenue (%): 38.71299871299871
Free cash flow (dilution-adjusted): 56000000
Buyback yield (%): 0.47156116757930255
Retained earnings: 19771000000
Receivables turnover: 0.6424673391764512
Capitalized R&D asset: 1612980000
ROCI (R&D-adjusted, %): 2.174578589881075
Rosenberg metric: 0.08114856429463171
FCF margin (%): 1.4414414414414414
Revenue growth (%): 1.4095536413469067
Rule of 40 score: 2.850995082788348
Financial ratios for ITU.DE — quarterly report dated 2026-01-31
Total revenue: 4651000000
Gross profit: 3608000000
Operating income: 855000000
Net income: 693000000
Capital expenditures: 46000000
Operating cash flow: 1570000000
Depreciation & amortization: 209000000
Net tangible assets: 101000000
Owner earnings: 856000000
Return on net tangible assets (%): 847.5247524752476
Capex to operating income (%): 5.380116959064328
Buffett classification: The Great
Stock price: 499.1666666666667
P/E ratio: 31.460956797235024
Shares outstanding: 273537000
Book value: 19055000000
P/B ratio: 7.165602335345054
Market cap (USD): 136540552500
Debt to equity: 0.3614799265284702
Current ratio: 1.3232700135685211
Quick ratio: 1.3232700135685211
Effective tax rate (%): 20.253164556962027
Interest coverage ratio: 14.741379310344827
COGS to revenue (%): 22.425284884970974
R&D to revenue (%): 17.97462911201892
SG&A to revenue (%): 38.6153515373038
Free cash flow (dilution-adjusted): 1003000000
Buyback yield (%): 0.6833134793416044
Retained earnings: 20123000000
Receivables turnover: 0.6309007053716766
Capitalized R&D asset: 1665140000
ROCI (R&D-adjusted, %): 3.1890523877799155
Rosenberg metric: 0.7188612099644128
FCF margin (%): 21.565254783917435
Revenue growth (%): 19.716859716859716
Rule of 40 score: 41.282114500777155
Financial ratios for KNSL — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 235.96
Shares outstanding: 22778425
Market cap (USD): 5374797163
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KNSL — annual report dated 2022-12-31
Total revenue: 838804000
Net income: 159114000
Capital expenditures: 6901000
Operating cash flow: 557815000
Depreciation & amortization: 2721000
Net tangible assets: 741911000
Owner earnings: 154934000
Return on net tangible assets (%): 20.883097837880822
Buffett classification: The Gruesome
Stock price: 259.95
P/E ratio: 37.213894306912024
Shares outstanding: 22778425
Book value: 745449000
P/B ratio: 7.9432014514071385
Market cap (USD): 5921251578.75
Debt to equity: 0.26258939243328516
Effective tax rate (%): 18.638399705467265
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 544236000
Buyback yield (%): 0
Retained earnings: 533121000
Receivables turnover: 2.5713777712379833
Capitalized R&D asset: 0
FCF margin (%): 64.88238015078612
Rule of 40 score: 64.88238015078612
Financial ratios for KNSL — annual report dated 2023-12-31
Total revenue: 1224449000
Net income: 308093000
Capital expenditures: 6607000
Operating cash flow: 859835000
Depreciation & amortization: 3274000
Net tangible assets: 1083294000
Owner earnings: 304760000
Return on net tangible assets (%): 28.13271374160662
Buffett classification: The Gruesome
Stock price: 333.45
P/E ratio: 24.65315932608011
Shares outstanding: 22778425
Book value: 1086832000
P/B ratio: 6.988629168307521
Market cap (USD): 7595465816.25
Debt to equity: 0.16915769870596375
Effective tax rate (%): 19.770999721366504
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 843867000
Buyback yield (%): 0
Retained earnings: 828247000
Receivables turnover: 3.131198727521941
Capitalized R&D asset: 0
FCF margin (%): 68.91810112140236
Revenue growth (%): 45.97557951559602
Rule of 40 score: 114.89368063699837